Clinical-stage biopharmaceutical company NovaBay Pharmaceuticals announced it has expanded its NeutraPhase commercial partnership agreement with Shanghai-based China Pioneer Pharma Holdings Limited. The new agreement replaces the former option to invest $3 million in NovaBay, and…
Cbeyond was recognized by the International Association of Business Communicators (IABC) for communication excellence at the 2013 Golden Flame Awards. The Golden Flame Awards are IBAC’s highest honor. They acknowledge merit for form, function, process…
CIS is channeling sideways between $1.93 and $1.96 as part of a longer-term uptrend in 2013. The stock has made a habit of sideways movement before making another climb upward, putting the chart on watch…